HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
901	24454 Brown DR Metalloproteins and neuronal death METALLOMICS. 2010; 2 (3): 186-194	0	3	44	126
902	24458 Kiris E, Ventimiglia D, Feinstein SC Quantitative Analysis of MAP-Mediated Regulation of Microtubule Dynamic Instability In Vitro-Focus on Tau METHODS IN CELL BIOLOGY, VOL 95. 2010; 95: 481-503	0	0	44	122
903	24553 Nagley P, Higgins GC, Atkin JD, Beart PM Multifaceted deaths orchestrated by mitochondria in neurones BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 JAN; 1802 (1): 167-185	1	9	44	321
904	24876 Crews L, Spencer B, Desplats P, Patrick C, Paulino A, et al. Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of alpha-Synucleinopathy PLOS ONE. 2010 FEB 19; 5 (2): Art. No. e9313	3	5	44	89
905	26152 Jaworski T, Dewachter I, Seymour CM, Borghgraef P, Devijver H, et al. Alzheimer's disease: Old problem, new views from transgenic and viral models BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 OCT; 1802 (10): 808-818	0	1	44	85
906	4081 Harrington CR, Wischik CM The impact of genetic and environmental factors on the pathobiology of Alzheimer's disease: A multifactorial disorder? INTERNATIONAL REVIEW OF PSYCHIATRY. 1995 DEC; 7 (3-4): 361-383	0	3	43	169
907	4310 Merrick SE, Demoise DC, Lee VMY Site-specific dephosphorylation of tau protein at Ser(202)/Thr(205) in response to microtubule depolymerization in cultured human neurons involves protein phosphatase 2A JOURNAL OF BIOLOGICAL CHEMISTRY. 1996 MAR 8; 271 (10): 5589-5594	51	62	43	67
908	4992 Reynolds CH, Utton MA, Gibb GM, Yates A, Anderton BH Stress-activated protein kinase/c-Jun N-terminal kinase phosphorylates tau protein JOURNAL OF NEUROCHEMISTRY. 1997 APR; 68 (4): 1736-1744	76	133	43	75
909	6578 Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling PROGRESS IN NEUROBIOLOGY. 1998 DEC; 56 (5): 541-569	33	122	43	384
910	8204 Hall GF, Chu BY, Lee G, Yao J Human tau filaments induce microtubule and synapse loss in an in vivo model of neurofibrillary degenerative disease JOURNAL OF CELL SCIENCE. 2000 APR; 113 (8): 1373-1387	33	41	43	71
#	Date / Author / Journal	LCS	GCS	LCR	CR
911	8429 Evert BO, Wullner U, Klockgether T Cell death in polyglutamine diseases CELL AND TISSUE RESEARCH. 2000 JUL; 301 (1): 189-204	21	57	43	138
912	8562 Zhang Y, Dawson VL, Dawson TM Oxidative stress and genetics in the pathogenesis of Parkinson's disease NEUROBIOLOGY OF DISEASE. 2000 AUG; 7 (4): 240-250	78	211	43	123
913	9271 Sieradzan KA, Mann DMA The selective vulnerability of nerve cells in Huntington's disease NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2001 FEB; 27 (1): 1-21	9	64	43	174
914	11214 Armstrong RA, Cairns NJ, Lantos PL Are pathological lesions in neurodegenerative disorders the cause or the effect of the degeneration? NEUROPATHOLOGY. 2002 SEP; 22 (3): 133-146	3	3	43	105
915	11624 Giasson BI, Sampathu DM, Wilson CA, Vogelsberg-Ragaglia V, Mushynski WE, et al. The environmental toxin arsenite induces tau hyperphosphorylation BIOCHEMISTRY. 2002 DEC 24; 41 (51): 15376-15387	6	9	43	95
916	12578 Ito T, Niwa J, Hishikawa N, Ishigaki S, Doyu M, et al. Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1 JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 AUG 1; 278 (31): 29106-29114	25	39	43	61
917	12625 Giasson BI, Mabon ME, Duda JE, Montine TJ, Robertson D, et al. Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy ACTA NEUROPATHOLOGICA. 2003 SEP; 106 (3): 243-250	17	17	43	75
918	13668 Raghupathi R Cell death mechanisms following traumatic brain BRAIN PATHOLOGY. 2004 APR; 14 (2): 215-222	33	116	43	126
919	13771 Hokenson MJ, Uversky VN, Goers J, Yamin G, Munishkina LA, et al. Role of individual methionines in the fibrillation of methionine- oxidized alpha-synuclein BIOCHEMISTRY. 2004 APR 20; 43 (15): 4621-4633	26	36	43	86
920	14398 Ekshyyan O, Aw TY Apoptosis: A key in Neurodegenerative disorders CURRENT NEUROVASCULAR RESEARCH. 2004 OCT; 1 (4): 355-371	1	33	43	259
#	Date / Author / Journal	LCS	GCS	LCR	CR
921	14618 Strong MJ Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2004 DEC; 13 (12): 1593-1614	0	10	43	302
922	14782 Dziewulska D, Rafalowska J Proteinaceous intracellular inclusions in neurodegenerative disorders FOLIA NEUROPATHOLOGICA. 2005; 43 (2): 51-63	1	3	43	85
923	14805 Papachroni K, Ninkina N, Wanless J, Kalofoutis AT, Gnuchev NV, et al. Peripheral sensory neurons survive in the absence of alpha- and gamma- synucleins JOURNAL OF MOLECULAR NEUROSCIENCE. 2005; 25 (2): 157-164	8	10	43	52
924	14873 Dickson D Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases ACTA NEUROPATHOLOGICA. 2005 JAN; 109 (1): 14-24	17	25	43	85
925	14990 Glaser CB, Yamin G, Uversky VN, Fink AL Methionine oxidation, alpha-synuclein and Parkinson's disease BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2005 JAN 17; 1703 (2): 157-169	29	58	43	117
926	15357 Rockenstein E, Schwach G, Ingolic E, Adame A, Crews L, et al. Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein JOURNAL OF NEUROSCIENCE RESEARCH. 2005 APR 15; 80 (2): 247-259	21	25	43	56
927	15583 Baker KA, Mendez I Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain JOURNAL OF COMPARATIVE NEUROLOGY. 2005 JUN 13; 486 (4): 318-330	4	5	43	88
928	15870 Ross CA, Margolis RL Neurogenetics: insights into degenerative diseases and approaches to schizophrenia CLINICAL NEUROSCIENCE RESEARCH. 2005 SEP; 5 (1): 3-14	1	6	43	147
929	15988 Jain S, Wood NW, Healy DG Molecular genetic pathways in Parkinson's disease: a review CLINICAL SCIENCE. 2005 OCT; 109 (4): 355-364	2	14	43	123
930	16172 Bandopadhyay R, Kingsbury AE, Muqit MM, Harvey K, Reid AR, et al. Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition NEUROBIOLOGY OF DISEASE. 2005 NOV; 20 (2): 401-411	14	17	43	57
#	Date / Author / Journal	LCS	GCS	LCR	CR
931	16477 Ginsberg SD, Mirnics K Functional genomic methodologies FUNCTIONAL GENOMICS AND PROTEOMICS IN THE CLINICAL NEUROSCIENCES. 2006; 158: 15-40	3	6	43	201
932	18736 Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, et al. DLB and PDD boundary issues - Diagnosis, treatment, molecular pathology, and biomarkers NEUROLOGY. 2007 MAR 13; 68 (11): 812-819	105	105	43	86
933	19000 Zana M, Janka Z, Kalman J Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease NEUROBIOLOGY OF AGING. 2007 MAY; 28 (5): 648-676	2	20	43	384
934	19425 Hegde ML, Rao KSJ DNA induces folding in alpha-synuclein: Understanding the mechanism using chaperone property of osmolytes ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2007 AUG 1; 464 (1): 57-69	1	5	43	95
935	19467 Braak H, Sastre M, Del Tredici K Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease ACTA NEUROPATHOLOGICA. 2007 SEP; 114 (3): 231-241	17	24	43	73
936	19710 Li M, Chen L, Lee DHS, Yu LC, Zhang Y The role of intracellular amyloid beta in Alzheimer's disease PROGRESS IN NEUROBIOLOGY. 2007 OCT; 83 (3): 131-139	5	19	43	132
937	19831 Fasano M, Bergamasco B, Lopiano L The proteomic approach in Parkinson's disease PROTEOMICS CLINICAL APPLICATIONS. 2007 NOV; 1 (11): 1428-1435	2	5	43	90
938	19908 Sikkink S, Rollinson S, Pickering-Brown SM The genetics of frontotemporal lobar degeneration CURRENT OPINION IN NEUROLOGY. 2007 DEC; 20 (6): 693-698	2	4	43	66
939	20139 Honson NS, Kuret J Tau aggregation and toxicity in tauopathic neurodegenerative diseases JOURNAL OF ALZHEIMERS DISEASE. 2008; 14 (4): 417-422	5	6	43	62
940	20296 Spina S, Farlow MR, Unverzagt FW, Kareken DA, Murrell JR, et al. The tauopathy associated with mutation+3 in intron 10 of Tau: characterization of the MSTD family BRAIN. 2008 JAN; 131: 72-89	3	3	43	67
#	Date / Author / Journal	LCS	GCS	LCR	CR
941	20843 Grundemann J, Schlaudraff F, Haeckel O, Liss B Elevated alpha-synuclein mRNA levels in individual UV-laser- microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease NUCLEIC ACIDS RESEARCH. 2008 APR; 36 (7): Art. No. e38	10	18	43	89
942	21266 Tumani H, Teunissen C, Sossmuth S, Otto M, Ludolph AC, et al. Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2008 JUL; 8 (4): 479-494	2	13	43	159
943	21385 Bigio EH TAR DNA-binding protein-43 in amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer disease ACTA NEUROPATHOLOGICA. 2008 AUG; 116 (2): 135-140	10	10	43	60
944	21663 Aluise CD, Sowell RA, Butterfield DA Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2008 OCT; 1782 (10): 549-558	2	5	43	159
945	22468 Pandey AP, Haque F, Rochet JC, Hovis JS Clustering of alpha-Synuclein on Supported Lipid Bilayers: Role of Anionic Lipid, Protein, and Divalent Ion Concentration BIOPHYSICAL JOURNAL. 2009 JAN 21; 96 (2): 540-551	6	7	43	62
946	22948 Emadi S, Kasturirangan S, Wang MS, Schulz P, Sierks MR Detecting Morphologically Distinct Oligomeric Forms of alpha-Synuclein JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 APR 24; 284 (17): 11048-11058	8	9	43	66
947	23303 Leverenz JB, Quinn JF, Zabetian C, Zhang J, Montine KS, et al. Cognitive Impairment and Dementia in Patients with Parkinson Disease CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2009 JUL; 9 (10): 903-912	1	2	43	159
948	23466 Bamburg JR, Bloom GS Cytoskeletal Pathologies of Alzheimer Disease CELL MOTILITY AND THE CYTOSKELETON. 2009 AUG; 66 (8): 635-649	5	8	43	175
949	23503 Fujita M, Sekigawa A, Sekiyama K, Sugama S, Hashimoto M Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies? JOURNAL OF NEUROLOGY. 2009 AUG; 256: S286-S292	0	1	43	51
950	23563 Fournier M, Vitte J, Garrigue J, Langui D, Dullin JP, et al. Parkin Deficiency Delays Motor Decline and Disease Manifestation in a Mouse Model of Synucleinopathy PLOS ONE. 2009 AUG 14; 4 (8): Art. No. e6629	4	4	43	54
#	Date / Author / Journal	LCS	GCS	LCR	CR
951	23607 Yao Z, Wood NW Cell Death Pathways in Parkinson's Disease: Role of Mitochondria ANTIOXIDANTS & REDOX SIGNALING. 2009 SEP; 11 (9): 2135-2149	6	9	43	180
952	24736 Sleegers K, Brouwers N, Van Broeckhoven C Role of progranulin as a biomarker for Alzheimer's disease BIOMARKERS IN MEDICINE. 2010 FEB; 4 (1): 37-50	1	2	43	82
953	25041 Tsika E, Moysidou M, Guo J, Cushman M, Gannon P, et al. Distinct Region-Specific alpha-Synuclein Oligomers in A53T Transgenic Mice: Implications for Neurodegeneration JOURNAL OF NEUROSCIENCE. 2010 MAR 3; 30 (9): 3409-3418	2	2	43	55
954	25042 Loeb V, Yakunin E, Saada A, Sharon R The Transgenic Overexpression of alpha-Synuclein and Not Its Related Pathology Associates with Complex I Inhibition JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 MAR 5; 285 (10): 7334-7343	3	3	43	68
955	25293 Harrington AJ, Hamamichi S, Caldwell GA, Caldwell KA C. elegans as a Model Organism to Investigate Molecular Pathways Involved with Parkinson's Disease DEVELOPMENTAL DYNAMICS. 2010 MAY; 239 (5): 1282-1295	1	1	43	89
956	25329 Richardson RM, Singh A, Sun D, Fillmore HL, Dietrich DW, et al. Stem cell biology in traumatic brain injury: effects of injury and strategies for repair JOURNAL OF NEUROSURGERY. 2010 MAY; 112 (5): 1125-1138	0	2	43	130
957	25457 Hampel H, Shen Y, Walsh DM, Aisen P, Shaw LM, et al. Biological markers of amyloid beta-related mechanisms in Alzheimer's disease EXPERIMENTAL NEUROLOGY. 2010 JUN; 223 (2): 334-346	3	3	43	165
958	25753 Iqbal K, Wang XC, Blanchard J, Liu F, Gong CX, et al. Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial BIOCHEMICAL SOCIETY TRANSACTIONS. 2010 AUG; 38: 962-966	0	0	43	76
959	26465 Falzone TL, Gunawardena S, McCleary D, Reis GF, Goldstein LSB Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies HUMAN MOLECULAR GENETICS. 2010 NOV 15; 19 (22): 4399-4408	0	0	43	63
960	26874 Thomas B, Mandir AS, West N, Liu Y, Andrabi SA, et al. Resistance to MPTP-Neurotoxicity in alpha-Synuclein Knockout Mice Is Complemented by Human alpha-Synuclein and Associated with Increased beta-Synuclein and Akt Activation PLOS ONE. 2011 JAN 31; 6 (1): Art. No. e16706	0	0	43	73
#	Date / Author / Journal	LCS	GCS	LCR	CR
961	27030 Dewey CM, Cenik B, Sephton CF, Dries DR, Mayer P, et al. TDP-43 Is Directed to Stress Granules by Sorbitol, a Novel Physiological Osmotic and Oxidative Stressor MOLECULAR AND CELLULAR BIOLOGY. 2011 MAR; 31 (5): 1098-1108	0	0	43	77
962	4530 Lovestone S, Hartley CL, Pearce J, Anderton BH Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: The effects on the organization and stability of microtubules NEUROSCIENCE. 1996 AUG; 73 (4): 1145-1157	80	128	42	61
963	4890 Tu PH, Robinson KA, deSnoo F, Eyer J, Peterson A, et al. Selective degeneration of Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice JOURNAL OF NEUROSCIENCE. 1997 FEB 1; 17 (3): 1064-1074	50	50	42	84
964	4962 Romanski LM, Giguere M, Bates JF, GoldmanRakic PS Topographic organization of medial pulvinar connections with the prefrontal cortex in the rhesus monkey JOURNAL OF COMPARATIVE NEUROLOGY. 1997 MAR 17; 379 (3): 313-332	11	83	42	99
965	6982 Roloff EV, Platt B Biochemical dysfunction and memory loss: the case of Alzheimer's dementia CELLULAR AND MOLECULAR LIFE SCIENCES. 1999 APR; 55 (4): 601-616	2	10	42	157
966	7132 Spillantini MG, Tolnay M, Love S, Goedert M Microtubule-associated protein tau, heparan sulphate and alpha- synuclein in several neurodegenerative diseases with dementia ACTA NEUROPATHOLOGICA. 1999 JUN; 97 (6): 585-594	28	33	42	86
967	9019 Kril JJ, Halliday GM Alzheimer's disease: Its diagnosis and pathogenesis INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 48. 2001; 48: 167-217	6	14	42	285
968	9242 Garcia ML, Cleveland DV Going new places using an old MAP: tau, microtubules and human neurodegenerative disease CURRENT OPINION IN CELL BIOLOGY. 2001 FEB; 13 (1): 41-48	50	90	42	51
969	9256 Riederer BM, Mourton-Gilles C, Frey P, Delacourte A, Probst A Differential phosphorylation of tau proteins during kitten brain development and Alzheimer's disease JOURNAL OF NEUROCYTOLOGY. 2001 FEB; 30 (2): 145-158	7	13	42	68
970	10131 Tawana K, Ramsden DB Progressive supranuclear palsy JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY. 2001 DEC; 54 (6): 427-434	5	0	42	70
#	Date / Author / Journal	LCS	GCS	LCR	CR
971	10275 Crowther DC Familial conformational diseases and dementias HUMAN MUTATION. 2002; 20 (1): 1-14	4	24	42	154
972	10360 Hartig W, Bauer A, Brauer K, Grosche J, Hortobagyi T, et al. Functional recovery of cholinergic basal forebrain neurons under disease conditions: Old problems, new solutions? REVIEWS IN THE NEUROSCIENCES. 2002; 13 (2): 95-165	4	20	42	697
973	11276 Lansbury PT, Brice A Genetics of Parkinson's disease and biochemical studies of implicated gene products - Commentary CURRENT OPINION IN CELL BIOLOGY. 2002 OCT; 14 (5): 653-660	20	34	42	79
974	11665 Caughey B, Lansbury PT Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 267-298	165	586	42	199
975	11707 Dib M Amyotrophic lateral sclerosis - Progress and prospects for treatment DRUGS. 2003; 63 (3): 289-310	2	14	42	272
976	11796 Lim KL, Dawson VL, Dawson TM The cast of molecular characters in Parkinson's disease - Felons, conspirators, and suspects PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 80-92	8	16	42	59
977	12117 Stanford PM, Shepherd CE, Halliday GM, Brooks WS, Schofield PW, et al. Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia BRAIN. 2003 APR; 126: 814-826	52	59	42	47
978	12304 Jiang ZH, Tang H, Havlioglu N, Zhang XC, Stamm S, et al. Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 MAY 23; 278 (21): 18997-19007	34	55	42	80
979	13554 Bonifati V, Oostra BA, Heutink P Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease JOURNAL OF MOLECULAR MEDICINE-JMM. 2004 MAR; 82 (3): 163-174	22	44	42	112
980	14044 Yoshida H, Hastie CJ, McLauchlan H, Cohen P, Goedert M Phosphorylation of microtubule-associated protein tau by isoforms of c- Jun N-terminal kinase (JNK) JOURNAL OF NEUROCHEMISTRY. 2004 JUL; 90 (2): 352-358	20	52	42	50
#	Date / Author / Journal	LCS	GCS	LCR	CR
981	14642 Neumann M, Muller V, Kretzschmar HA, Haass C, Kahle PJ Regional distribution of proteinase K-resistant alpha-synuclein correlates with Lewy body disease stage JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2004 DEC; 63 (12): 1225-1235	15	17	42	43
982	14760 Wu CY, Pike VW, Wang YM Amyloid imaging: From benchtop to bedside CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOLUME 70. 2005; 70: 171-+	7	17	42	134
983	15085 Chong ZZ, Li FQ, Maiese K Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease PROGRESS IN NEUROBIOLOGY. 2005 FEB; 75 (3): 207-246	10	138	42	502
984	15145 Zabrocki P, Pellens K, Vanhelmont T, Vandebroek T, Griffioen G, et al. Characterization of alpha-synuclein aggregation and synergistic toxicity with protein tau in yeast FEBS JOURNAL. 2005 MAR; 272 (6): 1386-1400	18	26	42	68
985	15264 Rubinszfein DC, DiFiglia M, Heintz N, Nixon RA, Qin ZH, et al. Autophagy and its possible roles in nervous system diseases, damage and repair AUTOPHAGY. 2005 APR-JUN; 1 (1): 11-22	24	127	42	182
986	15297 Villemagne VL, Rowe CC, Macfarlane S, Novakovic KE, Masters CL Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease JOURNAL OF CLINICAL NEUROSCIENCE. 2005 APR; 12 (3): 221-230	11	17	42	174
987	15335 Lee HG, Perry G, Moreira PI, Garrett MR, Liu Q, et al. Tau phosphorylation in Alzheimer's disease: pathogen or protector? TRENDS IN MOLECULAR MEDICINE. 2005 APR; 11 (4): 164-169	45	77	42	90
988	15599 Lee HJ, Patel S, Lee SJ Intravesicular localization and exocytosis of alpha-synuclein and its aggregates JOURNAL OF NEUROSCIENCE. 2005 JUN 22; 25 (25): 6016-6024	78	101	42	63
989	15756 Meriin AB, Sherman MY Role of molecular chaperones in neurodegenerative disorders INTERNATIONAL JOURNAL OF HYPERTHERMIA. 2005 AUG; 21 (5): 403-419	17	43	42	130
990	15846 Gille G, Reichmann H Update on etiopathogenesis of idiopathic Parkinson's syndrome AKTUELLE NEUROLOGIE. 2005 SEP; 32: S75-S87	0	0	42	146
#	Date / Author / Journal	LCS	GCS	LCR	CR
991	16264 Schmidt O, Schulenborg T, Meyer HE, Marcus K, Hamacher M How proteomics reveals potential biomarkers in brain diseases EXPERT REVIEW OF PROTEOMICS. 2005 DEC; 2 (6): 901-913	1	12	42	155
992	16431 Herbst M, Wanker EE Therapeutic approaches to polyglutamine diseases: Combating protein misfolding and aggregation CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (20): 2543-2555	6	11	42	176
993	17130 Betarbet R, Canet-Aviles RA, Sherer TB, Mastroberardino PG, McLendon C, et al. Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system NEUROBIOLOGY OF DISEASE. 2006 MAY; 22 (2): 404-420	34	82	42	78
994	17580 Springer W, Kahle PJ Mechanisms and models of alpha-synuclein-related neurodegeneration CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS. 2006 SEP; 6 (5): 432-436	10	10	42	48
995	17683 Eyal A, Engelender S Synphilin isoforms and the search for a cellular model of Lewy body formation in Parkinson's disease CELL CYCLE. 2006 SEP 15; 5 (18): 2082-2086	6	6	42	60
996	17713 Hardy J, Cai HB, Cookson MR, Gwinn-Hardy K, Singleton A Genetics of Parkinson's disease and parkinsonism ANNALS OF NEUROLOGY. 2006 OCT; 60 (4): 389-398	64	131	42	86
997	17737 Klucken J, Outeiro TF, Nguyen P, McLean PJ, Hyman BT Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging FASEB JOURNAL. 2006 OCT; 20 (12): 2050-2057	12	18	42	47
998	18023 Lee HJ, Khoshaghideh F, Lee S, Lee SJ Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein EUROPEAN JOURNAL OF NEUROSCIENCE. 2006 DEC; 24 (11): 3153-3162	16	25	42	64
999	18256 Gnanapavan S, Giovannoni G Incorporation of other biomarkers NEURODEGENERATION IN MULTIPLE SCLEROSIS. 2007; : 183-207	0	0	42	146
1000	18948 Seelaar H, Schelhaas HJ, Azmani A, Kusters B, Rosso S, et al. TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations BRAIN. 2007 MAY; 130: 1375-1385	46	47	42	69

Date / Author / Journal

901

Metalloproteins and neuronal death

METALLOMICS. 2010; 2 (3): 186-194

126

902

24458 Kiris E, Ventimiglia D, Feinstein SC

Quantitative Analysis of MAP-Mediated Regulation of Microtubule Dynamic Instability In Vitro-Focus on Tau

METHODS IN CELL BIOLOGY, VOL 95. 2010; 95: 481-503

122

903

24553 Nagley P, Higgins GC, Atkin JD, Beart PM

Multifaceted deaths orchestrated by mitochondria in neurones

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 JAN; 1802 (1): 167-185

321

904

24876 Crews L, Spencer B, Desplats P, Patrick C, Paulino A, et al.

Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of alpha-Synucleinopathy

PLOS ONE. 2010 FEB 19; 5 (2): Art. No. e9313

905

26152 Jaworski T, Dewachter I, Seymour CM, Borghgraef P, Devijver H, et al.

Alzheimer's disease: Old problem, new views from transgenic and viral models

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 OCT; 1802 (10): 808-818

906

4081 Harrington CR, Wischik CM

The impact of genetic and environmental factors on the pathobiology of Alzheimer's disease: A multifactorial disorder?

INTERNATIONAL REVIEW OF PSYCHIATRY. 1995 DEC; 7 (3-4): 361-383

169

907

4310 Merrick SE, Demoise DC, Lee VMY

Site-specific dephosphorylation of tau protein at Ser(202)/Thr(205) in response to microtubule depolymerization in cultured human neurons involves protein phosphatase 2A

JOURNAL OF BIOLOGICAL CHEMISTRY. 1996 MAR 8; 271 (10): 5589-5594

908

4992 Reynolds CH, Utton MA, Gibb GM, Yates A, Anderton BH

Stress-activated protein kinase/c-Jun N-terminal kinase phosphorylates tau protein

JOURNAL OF NEUROCHEMISTRY. 1997 APR; 68 (4): 1736-1744

133

909

6578 Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V

The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling

PROGRESS IN NEUROBIOLOGY. 1998 DEC; 56 (5): 541-569

122

384

910

8204 Hall GF, Chu BY, Lee G, Yao J

Human tau filaments induce microtubule and synapse loss in an in vivo model of neurofibrillary degenerative disease

JOURNAL OF CELL SCIENCE. 2000 APR; 113 (8): 1373-1387

Date / Author / Journal

LCS

GCS

LCR

911

8429 Evert BO, Wullner U, Klockgether T

Cell death in polyglutamine diseases

CELL AND TISSUE RESEARCH. 2000 JUL; 301 (1): 189-204

138

912

8562 Zhang Y, Dawson VL, Dawson TM

Oxidative stress and genetics in the pathogenesis of Parkinson's disease

NEUROBIOLOGY OF DISEASE. 2000 AUG; 7 (4): 240-250

211

123

913

9271 Sieradzan KA, Mann DMA

The selective vulnerability of nerve cells in Huntington's disease

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2001 FEB; 27 (1): 1-21

174

914

11214 Armstrong RA, Cairns NJ, Lantos PL

Are pathological lesions in neurodegenerative disorders the cause or the effect of the degeneration?

NEUROPATHOLOGY. 2002 SEP; 22 (3): 133-146

105

915

11624 Giasson BI, Sampathu DM, Wilson CA, Vogelsberg-Ragaglia V, Mushynski WE, et al.

The environmental toxin arsenite induces tau hyperphosphorylation

BIOCHEMISTRY. 2002 DEC 24; 41 (51): 15376-15387

916

12578 Ito T, Niwa J, Hishikawa N, Ishigaki S, Doyu M, et al.

Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1

JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 AUG 1; 278 (31): 29106-29114

917

12625 Giasson BI, Mabon ME, Duda JE, Montine TJ, Robertson D, et al.

Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy

ACTA NEUROPATHOLOGICA. 2003 SEP; 106 (3): 243-250

918

13668 Raghupathi R

Cell death mechanisms following traumatic brain

BRAIN PATHOLOGY. 2004 APR; 14 (2): 215-222

116

126

919

13771 Hokenson MJ, Uversky VN, Goers J, Yamin G, Munishkina LA, et al.

Role of individual methionines in the fibrillation of methionine- oxidized alpha-synuclein

BIOCHEMISTRY. 2004 APR 20; 43 (15): 4621-4633

920

14398 Ekshyyan O, Aw TY

Apoptosis: A key in Neurodegenerative disorders

CURRENT NEUROVASCULAR RESEARCH. 2004 OCT; 1 (4): 355-371

259

Date / Author / Journal

921

Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy

EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2004 DEC; 13 (12): 1593-1614

302

922

14782 Dziewulska D, Rafalowska J

Proteinaceous intracellular inclusions in neurodegenerative disorders

FOLIA NEUROPATHOLOGICA. 2005; 43 (2): 51-63

923

14805 Papachroni K, Ninkina N, Wanless J, Kalofoutis AT, Gnuchev NV, et al.

Peripheral sensory neurons survive in the absence of alpha- and gamma- synucleins

JOURNAL OF MOLECULAR NEUROSCIENCE. 2005; 25 (2): 157-164

924

14873 Dickson D

Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases

ACTA NEUROPATHOLOGICA. 2005 JAN; 109 (1): 14-24

925

14990 Glaser CB, Yamin G, Uversky VN, Fink AL

Methionine oxidation, alpha-synuclein and Parkinson's disease

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2005 JAN 17; 1703 (2): 157-169

117

926

15357 Rockenstein E, Schwach G, Ingolic E, Adame A, Crews L, et al.

Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein

JOURNAL OF NEUROSCIENCE RESEARCH. 2005 APR 15; 80 (2): 247-259

927

15583 Baker KA, Mendez I

Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain

JOURNAL OF COMPARATIVE NEUROLOGY. 2005 JUN 13; 486 (4): 318-330

928

15870 Ross CA, Margolis RL

Neurogenetics: insights into degenerative diseases and approaches to schizophrenia

CLINICAL NEUROSCIENCE RESEARCH. 2005 SEP; 5 (1): 3-14

147

929

15988 Jain S, Wood NW, Healy DG

Molecular genetic pathways in Parkinson's disease: a review

CLINICAL SCIENCE. 2005 OCT; 109 (4): 355-364

123

930

16172 Bandopadhyay R, Kingsbury AE, Muqit MM, Harvey K, Reid AR, et al.

Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition

NEUROBIOLOGY OF DISEASE. 2005 NOV; 20 (2): 401-411

Date / Author / Journal

LCS

GCS

LCR

931

16477 Ginsberg SD, Mirnics K

Functional genomic methodologies

FUNCTIONAL GENOMICS AND PROTEOMICS IN THE CLINICAL NEUROSCIENCES. 2006; 158: 15-40

201

932

18736 Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, et al.

DLB and PDD boundary issues - Diagnosis, treatment, molecular pathology, and biomarkers

NEUROLOGY. 2007 MAR 13; 68 (11): 812-819

105

933

19000 Zana M, Janka Z, Kalman J

Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease

NEUROBIOLOGY OF AGING. 2007 MAY; 28 (5): 648-676

384

934

19425 Hegde ML, Rao KSJ

DNA induces folding in alpha-synuclein: Understanding the mechanism using chaperone property of osmolytes

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2007 AUG 1; 464 (1): 57-69

935

19467 Braak H, Sastre M, Del Tredici K

Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease

ACTA NEUROPATHOLOGICA. 2007 SEP; 114 (3): 231-241

936

19710 Li M, Chen L, Lee DHS, Yu LC, Zhang Y

The role of intracellular amyloid beta in Alzheimer's disease

PROGRESS IN NEUROBIOLOGY. 2007 OCT; 83 (3): 131-139

132

937

19831 Fasano M, Bergamasco B, Lopiano L

The proteomic approach in Parkinson's disease

PROTEOMICS CLINICAL APPLICATIONS. 2007 NOV; 1 (11): 1428-1435

938

19908 Sikkink S, Rollinson S, Pickering-Brown SM

The genetics of frontotemporal lobar degeneration

CURRENT OPINION IN NEUROLOGY. 2007 DEC; 20 (6): 693-698

939

20139 Honson NS, Kuret J

Tau aggregation and toxicity in tauopathic neurodegenerative diseases

JOURNAL OF ALZHEIMERS DISEASE. 2008; 14 (4): 417-422

940

20296 Spina S, Farlow MR, Unverzagt FW, Kareken DA, Murrell JR, et al.

The tauopathy associated with mutation+3 in intron 10 of Tau: characterization of the MSTD family

BRAIN. 2008 JAN; 131: 72-89

Date / Author / Journal

LCS

GCS

LCR

941

20843 Grundemann J, Schlaudraff F, Haeckel O, Liss B

Elevated alpha-synuclein mRNA levels in individual UV-laser- microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease

NUCLEIC ACIDS RESEARCH. 2008 APR; 36 (7): Art. No. e38

942

21266 Tumani H, Teunissen C, Sossmuth S, Otto M, Ludolph AC, et al.

Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2008 JUL; 8 (4): 479-494

159

943

21385 Bigio EH

TAR DNA-binding protein-43 in amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer disease

ACTA NEUROPATHOLOGICA. 2008 AUG; 116 (2): 135-140

944

21663 Aluise CD, Sowell RA, Butterfield DA

Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2008 OCT; 1782 (10): 549-558

159

945

22468 Pandey AP, Haque F, Rochet JC, Hovis JS

Clustering of alpha-Synuclein on Supported Lipid Bilayers: Role of Anionic Lipid, Protein, and Divalent Ion Concentration

BIOPHYSICAL JOURNAL. 2009 JAN 21; 96 (2): 540-551

946

22948 Emadi S, Kasturirangan S, Wang MS, Schulz P, Sierks MR

Detecting Morphologically Distinct Oligomeric Forms of alpha-Synuclein

JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 APR 24; 284 (17): 11048-11058

947

23303 Leverenz JB, Quinn JF, Zabetian C, Zhang J, Montine KS, et al.

Cognitive Impairment and Dementia in Patients with Parkinson Disease

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2009 JUL; 9 (10): 903-912

159

948

23466 Bamburg JR, Bloom GS

Cytoskeletal Pathologies of Alzheimer Disease

CELL MOTILITY AND THE CYTOSKELETON. 2009 AUG; 66 (8): 635-649

175

949

23503 Fujita M, Sekigawa A, Sekiyama K, Sugama S, Hashimoto M

Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?

JOURNAL OF NEUROLOGY. 2009 AUG; 256: S286-S292

950

23563 Fournier M, Vitte J, Garrigue J, Langui D, Dullin JP, et al.

Parkin Deficiency Delays Motor Decline and Disease Manifestation in a Mouse Model of Synucleinopathy

PLOS ONE. 2009 AUG 14; 4 (8): Art. No. e6629

Date / Author / Journal

951

Cell Death Pathways in Parkinson's Disease: Role of Mitochondria

ANTIOXIDANTS & REDOX SIGNALING. 2009 SEP; 11 (9): 2135-2149

180

952

24736 Sleegers K, Brouwers N, Van Broeckhoven C

Role of progranulin as a biomarker for Alzheimer's disease

BIOMARKERS IN MEDICINE. 2010 FEB; 4 (1): 37-50

953

25041 Tsika E, Moysidou M, Guo J, Cushman M, Gannon P, et al.

Distinct Region-Specific alpha-Synuclein Oligomers in A53T Transgenic Mice: Implications for Neurodegeneration

JOURNAL OF NEUROSCIENCE. 2010 MAR 3; 30 (9): 3409-3418

954

25042 Loeb V, Yakunin E, Saada A, Sharon R

The Transgenic Overexpression of alpha-Synuclein and Not Its Related Pathology Associates with Complex I Inhibition

JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 MAR 5; 285 (10): 7334-7343

955

25293 Harrington AJ, Hamamichi S, Caldwell GA, Caldwell KA

C. elegans as a Model Organism to Investigate Molecular Pathways Involved with Parkinson's Disease

DEVELOPMENTAL DYNAMICS. 2010 MAY; 239 (5): 1282-1295

956

25329 Richardson RM, Singh A, Sun D, Fillmore HL, Dietrich DW, et al.

Stem cell biology in traumatic brain injury: effects of injury and strategies for repair

JOURNAL OF NEUROSURGERY. 2010 MAY; 112 (5): 1125-1138

130

957

25457 Hampel H, Shen Y, Walsh DM, Aisen P, Shaw LM, et al.

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

EXPERIMENTAL NEUROLOGY. 2010 JUN; 223 (2): 334-346

165

958

25753 Iqbal K, Wang XC, Blanchard J, Liu F, Gong CX, et al.

Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial

BIOCHEMICAL SOCIETY TRANSACTIONS. 2010 AUG; 38: 962-966

959

26465 Falzone TL, Gunawardena S, McCleary D, Reis GF, Goldstein LSB

Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies

HUMAN MOLECULAR GENETICS. 2010 NOV 15; 19 (22): 4399-4408

960

26874 Thomas B, Mandir AS, West N, Liu Y, Andrabi SA, et al.

Resistance to MPTP-Neurotoxicity in alpha-Synuclein Knockout Mice Is Complemented by Human alpha-Synuclein and Associated with Increased beta-Synuclein and Akt Activation

PLOS ONE. 2011 JAN 31; 6 (1): Art. No. e16706

Date / Author / Journal

LCS

GCS

LCR

961

27030 Dewey CM, Cenik B, Sephton CF, Dries DR, Mayer P, et al.

TDP-43 Is Directed to Stress Granules by Sorbitol, a Novel Physiological Osmotic and Oxidative Stressor

MOLECULAR AND CELLULAR BIOLOGY. 2011 MAR; 31 (5): 1098-1108

962

4530 Lovestone S, Hartley CL, Pearce J, Anderton BH

Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: The effects on the organization and stability of microtubules

NEUROSCIENCE. 1996 AUG; 73 (4): 1145-1157

128

963

4890 Tu PH, Robinson KA, deSnoo F, Eyer J, Peterson A, et al.

Selective degeneration of Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice

JOURNAL OF NEUROSCIENCE. 1997 FEB 1; 17 (3): 1064-1074

964

4962 Romanski LM, Giguere M, Bates JF, GoldmanRakic PS

Topographic organization of medial pulvinar connections with the prefrontal cortex in the rhesus monkey

JOURNAL OF COMPARATIVE NEUROLOGY. 1997 MAR 17; 379 (3): 313-332

965

6982 Roloff EV, Platt B

Biochemical dysfunction and memory loss: the case of Alzheimer's dementia

CELLULAR AND MOLECULAR LIFE SCIENCES. 1999 APR; 55 (4): 601-616

157

966

7132 Spillantini MG, Tolnay M, Love S, Goedert M

Microtubule-associated protein tau, heparan sulphate and alpha- synuclein in several neurodegenerative diseases with dementia

ACTA NEUROPATHOLOGICA. 1999 JUN; 97 (6): 585-594

967

9019 Kril JJ, Halliday GM

Alzheimer's disease: Its diagnosis and pathogenesis

INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 48. 2001; 48: 167-217

285

968

9242 Garcia ML, Cleveland DV

Going new places using an old MAP: tau, microtubules and human neurodegenerative disease

CURRENT OPINION IN CELL BIOLOGY. 2001 FEB; 13 (1): 41-48

969

9256 Riederer BM, Mourton-Gilles C, Frey P, Delacourte A, Probst A

Differential phosphorylation of tau proteins during kitten brain development and Alzheimer's disease

JOURNAL OF NEUROCYTOLOGY. 2001 FEB; 30 (2): 145-158

970

10131 Tawana K, Ramsden DB

Progressive supranuclear palsy

JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY. 2001 DEC; 54 (6): 427-434

Date / Author / Journal

971

Familial conformational diseases and dementias

HUMAN MUTATION. 2002; 20 (1): 1-14

154

972

10360 Hartig W, Bauer A, Brauer K, Grosche J, Hortobagyi T, et al.

Functional recovery of cholinergic basal forebrain neurons under disease conditions: Old problems, new solutions?

REVIEWS IN THE NEUROSCIENCES. 2002; 13 (2): 95-165

697

973

11276 Lansbury PT, Brice A

Genetics of Parkinson's disease and biochemical studies of implicated gene products - Commentary

CURRENT OPINION IN CELL BIOLOGY. 2002 OCT; 14 (5): 653-660

974

11665 Caughey B, Lansbury PT

Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders

ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 267-298

165

586

199

975

11707 Dib M

Amyotrophic lateral sclerosis - Progress and prospects for treatment

DRUGS. 2003; 63 (3): 289-310

272

976

11796 Lim KL, Dawson VL, Dawson TM

The cast of molecular characters in Parkinson's disease - Felons, conspirators, and suspects

PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 80-92

977

12117 Stanford PM, Shepherd CE, Halliday GM, Brooks WS, Schofield PW, et al.

Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia

BRAIN. 2003 APR; 126: 814-826

978

12304 Jiang ZH, Tang H, Havlioglu N, Zhang XC, Stamm S, et al.

Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta

JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 MAY 23; 278 (21): 18997-19007

979

13554 Bonifati V, Oostra BA, Heutink P

Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease

JOURNAL OF MOLECULAR MEDICINE-JMM. 2004 MAR; 82 (3): 163-174

112

980

14044 Yoshida H, Hastie CJ, McLauchlan H, Cohen P, Goedert M

Phosphorylation of microtubule-associated protein tau by isoforms of c- Jun N-terminal kinase (JNK)

JOURNAL OF NEUROCHEMISTRY. 2004 JUL; 90 (2): 352-358

Date / Author / Journal

LCS

GCS

LCR

981

14642 Neumann M, Muller V, Kretzschmar HA, Haass C, Kahle PJ

Regional distribution of proteinase K-resistant alpha-synuclein correlates with Lewy body disease stage

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2004 DEC; 63 (12): 1225-1235

982

14760 Wu CY, Pike VW, Wang YM

Amyloid imaging: From benchtop to bedside

CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOLUME 70. 2005; 70: 171-+

134

983

15085 Chong ZZ, Li FQ, Maiese K

Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease

PROGRESS IN NEUROBIOLOGY. 2005 FEB; 75 (3): 207-246

138

502

984

15145 Zabrocki P, Pellens K, Vanhelmont T, Vandebroek T, Griffioen G, et al.

Characterization of alpha-synuclein aggregation and synergistic toxicity with protein tau in yeast

FEBS JOURNAL. 2005 MAR; 272 (6): 1386-1400

985

15264 Rubinszfein DC, DiFiglia M, Heintz N, Nixon RA, Qin ZH, et al.

Autophagy and its possible roles in nervous system diseases, damage and repair

AUTOPHAGY. 2005 APR-JUN; 1 (1): 11-22

127

182

986

15297 Villemagne VL, Rowe CC, Macfarlane S, Novakovic KE, Masters CL

Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease

JOURNAL OF CLINICAL NEUROSCIENCE. 2005 APR; 12 (3): 221-230

174

987

15335 Lee HG, Perry G, Moreira PI, Garrett MR, Liu Q, et al.

Tau phosphorylation in Alzheimer's disease: pathogen or protector?

TRENDS IN MOLECULAR MEDICINE. 2005 APR; 11 (4): 164-169

988

15599 Lee HJ, Patel S, Lee SJ

Intravesicular localization and exocytosis of alpha-synuclein and its aggregates

JOURNAL OF NEUROSCIENCE. 2005 JUN 22; 25 (25): 6016-6024

101

989

15756 Meriin AB, Sherman MY

Role of molecular chaperones in neurodegenerative disorders

INTERNATIONAL JOURNAL OF HYPERTHERMIA. 2005 AUG; 21 (5): 403-419

130

990

15846 Gille G, Reichmann H

Update on etiopathogenesis of idiopathic Parkinson's syndrome

AKTUELLE NEUROLOGIE. 2005 SEP; 32: S75-S87

146

Date / Author / Journal

LCS

GCS

LCR

991

16264 Schmidt O, Schulenborg T, Meyer HE, Marcus K, Hamacher M

How proteomics reveals potential biomarkers in brain diseases

EXPERT REVIEW OF PROTEOMICS. 2005 DEC; 2 (6): 901-913

155

992

16431 Herbst M, Wanker EE

Therapeutic approaches to polyglutamine diseases: Combating protein misfolding and aggregation

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (20): 2543-2555

176

993

17130 Betarbet R, Canet-Aviles RA, Sherer TB, Mastroberardino PG, McLendon C, et al.

Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system

NEUROBIOLOGY OF DISEASE. 2006 MAY; 22 (2): 404-420

994

17580 Springer W, Kahle PJ

Mechanisms and models of alpha-synuclein-related neurodegeneration

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS. 2006 SEP; 6 (5): 432-436

995

17683 Eyal A, Engelender S

Synphilin isoforms and the search for a cellular model of Lewy body formation in Parkinson's disease

CELL CYCLE. 2006 SEP 15; 5 (18): 2082-2086

996

17713 Hardy J, Cai HB, Cookson MR, Gwinn-Hardy K, Singleton A

Genetics of Parkinson's disease and parkinsonism

ANNALS OF NEUROLOGY. 2006 OCT; 60 (4): 389-398

131

997

17737 Klucken J, Outeiro TF, Nguyen P, McLean PJ, Hyman BT

Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging

FASEB JOURNAL. 2006 OCT; 20 (12): 2050-2057

998

18023 Lee HJ, Khoshaghideh F, Lee S, Lee SJ

Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein

EUROPEAN JOURNAL OF NEUROSCIENCE. 2006 DEC; 24 (11): 3153-3162

999

18256 Gnanapavan S, Giovannoni G

Incorporation of other biomarkers

NEURODEGENERATION IN MULTIPLE SCLEROSIS. 2007; : 183-207

146

1000

18948 Seelaar H, Schelhaas HJ, Azmani A, Kusters B, Rosso S, et al.

TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations

BRAIN. 2007 MAY; 130: 1375-1385

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records